02:05 PM EST, 01/15/2025 (MT Newswires) -- Helius Medical Technologies ( HSDT ) shares were up more than 20% in recent trading Wednesday after the company said the newly published fee schedule payment rates for its portable neuromodulation stimulator are consistent with its preliminary reimbursement determination.

The Centers for Medicare and Medicaid Services on Monday posted final fee schedule payment rates for Medicare durable medical equipment, prosthetics, orthotics and supplies .

Price: 0.84, Change: +0.14, Percent Change: +20.49